Press release
Viscosupplementation Market to Reach USD 15.26 Billion by 2034, Growing at a 10.1% CAGR
๐๐ข๐ฌ๐๐จ๐ฌ๐ฎ๐ฉ๐ฉ๐ฅ๐๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฏ๐ข๐ฌ๐๐จ๐ฌ๐ฎ๐ฉ๐ฉ๐ฅ๐๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide viscosupplementation industry. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by product, end-use, and region in the study, which offers a comprehensive picture of the state of the market.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
In viscosupplementation, the healthcare donor injects hyaluronic acid into the joints. This dense fluid may assist in easing pain and swelling in the knee. The bones that constitute the joints usually have a cap of cartilage on their ends. This cartilage assists in ascertaining that the bones operate seamlessly against each other. This cartilage has a liquid coating that comprises hyaluronic acid.
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ:
โข Knee OA is one of the most customary configurations of arthritis, causing notable pain, decreased movements, and a degenerated standard of life for impacted persons. The knee is the most impacted joint, with 365 million cases, followed by the hip and hand.
โข The existence of age-connected illnesses, such as knee osteoarthritis (OA), is rising as the worldwide population matures. Elderly people are more susceptible to joint debasement, causing an elevated existence of knee OA, which is causing detrimental pain and impairment in this community.
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ:
The market is excessively aggressive, with both worldwide and domestic players struggling to brace up their positions through inventions, associations, and tactical augmentation. Here are the top companies in the viscosupplementation market:
โข Anika Therapeutics, Inc.
โข DePuy Synthes
โข F.Hoffmann-La Roche Ltd.
โข Ferring Pharmaceuticals B.V.
โข Fidia Farmaceutici S.p.A
โข LG Life Sciences Ltd.
โข Lifecore Biomedical
โข Sanofi
โข Seikagaku Corp.
โข Smith & Nephew PLC
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐:
https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market/request-for-discount-pricing
๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ ๐๐ข๐ฌ๐๐จ๐ฌ๐ฎ๐ฉ๐ฉ๐ฅ๐๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ
โข In terms of product, in 2024, the three injection segment accounted for the largest market share due to its established efficacy, widespread availability, and preference among healthcare providers for managing knee osteoarthritis.
โข Based on end use, the orthopedic clinics/ASCs segment is expected to witness the fastest growth during the forecast period due to increasing patient preference for specialized, cost-effective, and minimally invasive treatments offered in these settings.
โข In 2024, Asia Pacific accounted for the largest share of the viscosupplementation market due to the region's large aging population and increasing prevalence of knee osteoarthritis.
โข The Europe viscosupplementation market is expected to witness the fastest CAGR during the forecast period due to increasing demand for advanced osteoarthritis treatments.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
By Product Outlook (Revenue - USD Billion, 2020-2034)
โข Three Injection
โข Five Injection
โข Single Injection
By End Use Outlook (Revenue - USD Billion, 2020-2034)
โข Orthopedic Clinics/ASCs
โข Hospitals
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐:
https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market
๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐๐ข๐ฌ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ
According to regional research, Asia Pacific dominated the market. The region's growth is aided by an escalating aging population, the growing existence of knee osteoarthritis, and the growing consciousness of nonsurgical cure alternatives. Also, Europe is anticipated to emerge as the fastest-growing region in the viscosupplementation market.
โข North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Postpartum Products Market
https://www.polarismarketresearch.com/industry-analysis/postpartum-products-market
Medical Alert Systems Market
https://www.polarismarketresearch.com/industry-analysis/medical-alert-systems-market
Artificial Tendons and Ligaments Market
https://www.polarismarketresearch.com/industry-analysis/artificial-tendons-and-ligaments-market
Targeted Protein Degradation Market
https://www.polarismarketresearch.com/industry-analysis/targeted-protein-degradation-market
๐๐จ๐ง๐ญ๐๐๐ญ:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
๐๐๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก & ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐๐ง๐:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viscosupplementation Market to Reach USD 15.26 Billion by 2034, Growing at a 10.1% CAGR here
News-ID: 3865425 • Views: โฆ
More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ

Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ

Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ

Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for Viscosupplementation
Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statisticalโฆ
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boostโฆ
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise inโฆ
The three injection viscosupplementation product type segment is projected to be โฆ
Russiaโs healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by peopleโs eating & drink habits, their proactive lifestyles and the countryโs harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementationโฆ
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled โViscosupplementation Market: Russiaโฆ
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t โฆ
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled โViscosupplementation Market: Russiaโฆ